| editorial | Q871232 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1769-7255(09)70057-4 |
| P698 | PubMed publication ID | 19233074 |
| P50 | author | Christian Combe | Q41334325 |
| P2860 | cites work | Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial | Q34182887 |
| Biosimilar epoetins: an analysis based on recently implemented European medicines evaluation agency guidelines on comparability of biopharmaceutical proteins | Q36188312 | ||
| International Study of Health Care Organization and Financing for end-stage renal disease in France | Q36902918 | ||
| Novel erythropoiesis-stimulating agents: a new era in anemia management | Q37031261 | ||
| Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP). | Q50627188 | ||
| Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council | Q58948705 | ||
| P304 | page(s) | 1-2 | |
| P577 | publication date | 2009-02-01 | |
| P1433 | published in | Nephrologie & therapeutique | Q27721103 |
| P1476 | title | [Biological similarity of erythropoietin: controlled maturation] | |
| P478 | volume | 5 Spec No1 |
Search more.